Metastatic Trial Search provides clinical trial information in a patient-friendly format that makes it easy to understand what a trial is studying, who can...
The American Society of Clinical Oncology’s (ASCO) annual meeting was held online from June 4 through June 8, 2021. During the conference, researchers...
FDA Fast Track is a program to accelerate the development, review, and approval of new drugs to fill an unmet medical need, such as treatment for metastatic...
Immunotherapy is a type of treatment for MBC that increases the immune system’s ability to kill cancer cells. Many immunotherapy treatments are drugs. However,...
Knowing if you have an inherited (also called genetic) BRCA1 or BRCA2 mutation is a vital part of treatment planning for people diagnosed with breast cancer...
Researchers have made tremendous progress on cancer immunotherapy in the last decade. Immune checkpoint inhibitor drugs, adoptive cell therapies, and tumor...
The COVID-19 pandemic has impacted every aspect of the clinical trial process. However, it has also brought opportunities to modernize clinical trials. Read below...
Selective estrogen receptor degraders (SERDs) are a type of hormone therapy used to treat estrogen receptor-positive (ER+) MBC. Oral SERDs are taken by mouth....
The American Association for Cancer Research (AACR) is the largest cancer research organization dedicated to accelerating research to prevent and cure cancer. The...